Arena Pharma (ARNA) volatility suggested risk; shares down 44% on negative FDA vote
Tweet Send to a Friend
Arena Pharma (Nasdaq: ARNA) is recently down $1.71 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
